Karyopharm enters creditor forbearance pact after missing USD 15.8 million term-loan payment

PUBT · 1d ago
Karyopharm enters creditor forbearance pact after missing USD 15.8 million term-loan payment
  • Karyopharm signed a forbearance agreement on Sept. 10, 2026 with term-loan lenders, noteholders, royalty investors to delay enforcement on specified defaults.
  • Missed a USD 15.8 million term-loan principal installment due Sept. 10; does not expect to pay cash interest due Sept. 30.
  • Default-rate interest applies: term-loan obligations +2% per year from Sept. 10; unpaid term-loan interest +2% from Sept. 30.
  • Also missed June 30 cash interest on 9.00% Convertible Senior Notes due 2028 and 2029; defaulted amounts accrue an extra 2% per year.
  • Forbearance runs to Oct. 15, 2026 unless earlier termination; termination triggers immediate cash payment of overdue amounts, potential acceleration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-388621), on September 11, 2026, and is solely responsible for the information contained therein.